Mothers, newborns, young children and adolescents are losing 20 percent of their health and social services due to the COVID-19 pandemic says a Panel of senior global health experts.
Conflict and Health 2015, 9:8 doi:10.1186/s13031-015-0035-8
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...faster over the three-year estimated life of an ITN; therefore, the added impact of
pyrethroid-PBO ITNs over that of pyrethroid-only LLINs may decline over time. The evidence comes from two sites in
eastern Africa with pyrethroid resistance and not from other geographies where transmission levels and vector characteristics
may vary. PBO acts by inhibiting certain metabolic enzymes, primarily oxidases, and so are likely to provide greater protection
than pyrethroid-only LLINs where mosquitoes display mono-oxygenase-based insecticide resistance mechanisms.
more
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Information for policy-makers and planners on conducting deworming as part of an integrated
school health program
DHS Working Papers No. 102
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...fic to preventing transmission of Mycobacterium tuberculosis bridging with the core components of infection prevention and control programmes at the national and acute health care facility level
more
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin...g threats like climate change and antimicrobial resistance.
more
ein Lehr- & Lernheft für den Einstieg ins Deutsche mit Alltagsbezug entwickelt. Es gibt sieben Versionen zum Herunterladen. Gerne können die Hefte nicht-kommerziell und mit Qüllenangabe weiterverbreitet werden, vorzugsweise mit den Links von oben. Bestellen können Sie im Prinzip die Hefte mit En...glisch und Arabisch
more
Act on the Residence, Economic Activity and Integration of Foreigners in the Federal Territory
Residence Act. Translation provided by the Language Service of the Federal Ministry of the Interior.
Version information: The translation includes the amendment(s) to the Act by Article 3 of the Act of 6....9.2013 (Federal Law Gazette I p. 3556).
Translations may not be updated at the same time as the German legal provisions displayed on this website. To compare with the current status of the German version, see http://www.gesetze-im-internet.de/aufenthg_2004/BJNR195010004.html.
more
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ...(EMM)1 to help patients complete treatment and health-care workers to monitor both daily dosing and treatment continuity
more
Der Kinderrechte-Check richtet sich primär an Mitarbeiter*innen der Verwaltung, die für die Qualitätsaufsicht der Unterkünfte verantwortlich sind und Betreiber, Leitung und Mitarbeiter*innen von Unterkünften. Auch für politische Entscheidungsträger ist der Kinderrechte-Check von Interesse, da... er beschreibt, wie die Rechte geflüchteter Kinder gewahrt und gefördert werden können, während sie in Unterkünften untergebracht sind.
more
Background paper prepared for the Education for All Global Monitoring Report 2012
Reports from Kenya, Sierra Leone, China and Sri Lanka
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.